Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands
· Delayed Price · Currency is EUR
1.300
+0.010 (0.78%)
Apr 29, 2026, 5:35 PM CET
Vivoryon Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.85 | -20.57 | -28.34 | -28.16 | -12.66 | |
| Depreciation & Amortization | 0.15 | 0.15 | 0.17 | 0.16 | 0.17 | |
| Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.08 | |
| Stock-Based Compensation | 0.89 | 2.18 | 3.94 | 3.49 | 1.76 | |
| Provision & Write-off of Bad Debts | - | - | -0.04 | -0.05 | 0.1 | |
| Other Operating Activities | 0.07 | 0.77 | 2.97 | 1.73 | -0.13 | |
| Change in Accounts Payable | -0.55 | -1.9 | 0.54 | -1.72 | 3.45 | |
| Change in Other Net Operating Assets | -0.15 | 0.2 | -0.77 | 2.76 | -4.03 | |
| Operating Cash Flow | -8.46 | -19.17 | -21.54 | -21.79 | -11.26 | |
| Capital Expenditures | -0.01 | -0 | -0.01 | -0.01 | -0.02 | |
| Sale (Purchase) of Intangibles | - | - | -0.5 | -0 | -0.01 | |
| Investment in Securities | - | 10 | -10 | - | - | |
| Investing Cash Flow | -0.01 | 10 | -10.51 | -0.01 | -0.03 | |
| Long-Term Debt Repaid | -0.06 | -0.06 | -0.09 | -0.09 | -0.09 | |
| Net Debt Issued (Repaid) | -0.06 | -0.06 | -0.09 | -0.09 | -0.09 | |
| Issuance of Common Stock | 5.07 | - | 26.35 | 36 | 1.14 | |
| Other Financing Activities | -0.3 | - | -2.1 | -2.53 | -1.88 | |
| Financing Cash Flow | 4.72 | -0.06 | 24.16 | 33.38 | -0.83 | |
| Foreign Exchange Rate Adjustments | - | 0.04 | -0.1 | 0.32 | 0.47 | |
| Net Cash Flow | -3.75 | -9.2 | -7.99 | 11.89 | -11.65 | |
| Free Cash Flow | -8.46 | -19.18 | -21.56 | -21.81 | -11.28 | |
| Free Cash Flow Margin | - | - | - | - | -104.77% | |
| Free Cash Flow Per Share | -0.32 | -0.74 | -0.85 | -0.99 | -0.56 | |
| Cash Interest Paid | 0 | 0 | 0 | 0 | 0.01 | |
| Levered Free Cash Flow | -5.23 | -12.06 | -11.59 | -14.93 | -5.47 | |
| Unlevered Free Cash Flow | -5.2 | -12.03 | -11.55 | -14.91 | -5.46 | |
| Change in Working Capital | -0.71 | -1.7 | -0.24 | 1.03 | -0.58 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.